1.Clinical comprehensive evaluation of five marketed thrombopoietin receptor agonists in China
Yunjin ZHANG ; Xiaorong WU ; Zhiyun HUANG ; Meiyan ZHANG ; Fan ZHANG ; Hongtao LIU
China Pharmacy 2026;37(2):142-148
OBJECTIVE To conduct a clinical comprehensive evaluation of five marketed thrombopoietin receptor agonists (TPO-RA) approved in China, providing quantitative evidence for drug selection and therapeutic decision-making in medical institutions. METHODS Relevant data on Romiplostim for injection, Eltrombopag olamine tablets, Herombopag olamine tablets, Avatrombopag maleate tablets, and Lusutrombopag tablets were collected. Based on the Chinese Rapid Guide for Drug Evaluation and Selection in Medical Institutions (Second Edition), 12 formulations of these five TPO-RA were scored quantitatively and comparatively across five dimensions: pharmacological characteristics, efficacy, safety, cost-effectiveness, and other attributes. RESULTS The comprehensive scores of the 12 formulations ranged from 62.56 to 75.50 points, with most scoring ≥70 points. Using the highest-scoring formulation for each generic name as a representative, the overall rankings of the five TPO-RA were as follows: Lusutrombopag tablets (75.50 points), Eltrombopag olamine tablets (75.10 points), Avatrombopag maleate tablets (70.40 points), Romiplostim for injection (63.93 points), and Herombopag olamine tablets (63.52 points). Lusutrombopag tablets scored relatively high in pharmacological characteristics, safety, and cost-effectiveness, while Eltrombopag olamine tablets performed well in efficacy and cost-effectiveness. The other formulations showed varying scores across evaluation dimensions. CONCLUSIONS The five TPO-RA demonstrate favorable overall clinical value, with Lusutrombopag tablets and Eltrombopag olamine tablets ranking higher in comprehensive scores, these two drugs should be prioritized in drug selection and formula optimization by medical institutions.
2.Retrospective analysis of malignant tumor mortality cases at a specialized oncology hospital from 2019 to 2024
Huan WANG ; Hongtao WANG ; Lida FAN ; Chenyang LI ; Liang LI ; Xiaqing DU
Modern Hospital 2025;25(11):1770-1773
Objective This study aims to conduct a retrospective analysis of the malignant tumor mortality cases at a specialized oncology hospital,providing a reference for rationally allocating medical resources and early diagnosis and treatment of malignant tumors.Methods Demographic data and clinical records of deceased patients with malignant tumor at the hospital from 2019 to 2024 was collected and analyzed with SPSS 25.0 and R studio in terms of gender,age,mortality rate and death causes.Results Totally,862 inpatients were reported dead from 2019 to 2024,with a mortality rate of 0.32%.Among them,500(58.0%)had not received surgical treatments,and 561(65.1%)were documented as clinical/pathological stage Ⅳ.Overall,531 deaths occurred in men and 331 in women;the male mortality rate was significantly higher than the female(0.54%vs.0.19%,(x2=236.93,P=0.000).The highest annual tumor-related mortality rate was recorded in 2019(0.46%).The 75-and-older age group had the greatest mortality,with 113 deaths accounting for 1.23%;the age-specific distribution differed sig-nificantly between sexes(P<0.05).The top five causes of cancer death were lung cancer(206 cases,23.90%),liver cancer(88 cases,10.21%),gastric cancer(75 cases,8.70%),malignant lymphoma(73 cases,8.47%),pancreatic cancer(72 cases,8.35%).Conclusion The malignant tumor mortality rate is higher in males than in females,with the highest mortality observed in those aged 75 and above.Lung,liver and gastric cancers account for most cancer deaths.The hospital managers should strengthen health education for the elderly and simultaneously strengthen the diagnosis and treatment of these key cancers.
3.Efficacy of combined local and systemic therapy in CNLC stage Ⅲb hepatocellular carcinoma
Hanrui YANG ; Qinqiao FAN ; Liang XIAO ; Yulin XIE ; Shiqi LU ; Hongtao YUAN ; Ledu ZHOU
Chinese Journal of General Surgery 2025;34(7):1371-1381
Background and Aims:CNLC stage IIIb hepatocellular carcinoma(HCC)is often accompanied by extrahepatic metastases and carries a poor prognosis.The optimal treatment strategy for these patients remains controversial,and the role of local therapy lacks robust evidence.This study aimed to compare overall survival(OS)between patients receiving combined local and systemic therapy versus systemic therapy alone,and to assess the prognostic impact of oligometastatic status and the cumulative duration of no evidence of disease(NED).Methods:A retrospective analysis was conducted on 76 CNLC stage IIIb HCC patients treated at Xiangya Hospital from January 2017 to December 2023.Forty patients received systemic therapy plus local therapy(local therapy group),and 36 received systemic therapy alone(no local therapy group).OS was compared between the two groups.Subgroup analyses were performed for oligometastatic and non-oligometastatic patients to evaluate the benefit of local therapy.In the local therapy group,the correlation between cumulative NED duration and OS was also examined.Results:The 1-,2-,3-,and 5-year OS rates were 89.0%vs.66.7%,64.3%vs.25.6%,35.3%vs.8.7%,and 8.3%vs.0.0%for the local therapy and no local therapy groups,respectively,with a statistically significant difference(P=0.003).Among oligometastatic patients,the local therapy group had significantly better OS than the no local therapy group(P=0.008),whereas no significant difference was observed in non-oligometastatic patients(P>0.05).Multivariate analysis identified oligometastases as an independent prognostic factor(HR=2.213,P=0.045).In the local therapy group,cumulative NED duration was strongly correlated with OS(r=0.851,P<0.001).Local therapy was well tolerated,with no treatment-related deaths observed.Conclusion:For CNLC stage IIIb HCC patients with well-controlled intrahepatic disease,local therapy can significantly prolong survival,particularly in those with oligometastases.Achieving and maintaining NED may represent an important therapeutic goal in this patient population.
4.Efficacy of combined local and systemic therapy in CNLC stage Ⅲb hepatocellular carcinoma
Hanrui YANG ; Qinqiao FAN ; Liang XIAO ; Yulin XIE ; Shiqi LU ; Hongtao YUAN ; Ledu ZHOU
Chinese Journal of General Surgery 2025;34(7):1371-1381
Background and Aims:CNLC stage IIIb hepatocellular carcinoma(HCC)is often accompanied by extrahepatic metastases and carries a poor prognosis.The optimal treatment strategy for these patients remains controversial,and the role of local therapy lacks robust evidence.This study aimed to compare overall survival(OS)between patients receiving combined local and systemic therapy versus systemic therapy alone,and to assess the prognostic impact of oligometastatic status and the cumulative duration of no evidence of disease(NED).Methods:A retrospective analysis was conducted on 76 CNLC stage IIIb HCC patients treated at Xiangya Hospital from January 2017 to December 2023.Forty patients received systemic therapy plus local therapy(local therapy group),and 36 received systemic therapy alone(no local therapy group).OS was compared between the two groups.Subgroup analyses were performed for oligometastatic and non-oligometastatic patients to evaluate the benefit of local therapy.In the local therapy group,the correlation between cumulative NED duration and OS was also examined.Results:The 1-,2-,3-,and 5-year OS rates were 89.0%vs.66.7%,64.3%vs.25.6%,35.3%vs.8.7%,and 8.3%vs.0.0%for the local therapy and no local therapy groups,respectively,with a statistically significant difference(P=0.003).Among oligometastatic patients,the local therapy group had significantly better OS than the no local therapy group(P=0.008),whereas no significant difference was observed in non-oligometastatic patients(P>0.05).Multivariate analysis identified oligometastases as an independent prognostic factor(HR=2.213,P=0.045).In the local therapy group,cumulative NED duration was strongly correlated with OS(r=0.851,P<0.001).Local therapy was well tolerated,with no treatment-related deaths observed.Conclusion:For CNLC stage IIIb HCC patients with well-controlled intrahepatic disease,local therapy can significantly prolong survival,particularly in those with oligometastases.Achieving and maintaining NED may represent an important therapeutic goal in this patient population.
5.Retrospective analysis of malignant tumor mortality cases at a specialized oncology hospital from 2019 to 2024
Huan WANG ; Hongtao WANG ; Lida FAN ; Chenyang LI ; Liang LI ; Xiaqing DU
Modern Hospital 2025;25(11):1770-1773
Objective This study aims to conduct a retrospective analysis of the malignant tumor mortality cases at a specialized oncology hospital,providing a reference for rationally allocating medical resources and early diagnosis and treatment of malignant tumors.Methods Demographic data and clinical records of deceased patients with malignant tumor at the hospital from 2019 to 2024 was collected and analyzed with SPSS 25.0 and R studio in terms of gender,age,mortality rate and death causes.Results Totally,862 inpatients were reported dead from 2019 to 2024,with a mortality rate of 0.32%.Among them,500(58.0%)had not received surgical treatments,and 561(65.1%)were documented as clinical/pathological stage Ⅳ.Overall,531 deaths occurred in men and 331 in women;the male mortality rate was significantly higher than the female(0.54%vs.0.19%,(x2=236.93,P=0.000).The highest annual tumor-related mortality rate was recorded in 2019(0.46%).The 75-and-older age group had the greatest mortality,with 113 deaths accounting for 1.23%;the age-specific distribution differed sig-nificantly between sexes(P<0.05).The top five causes of cancer death were lung cancer(206 cases,23.90%),liver cancer(88 cases,10.21%),gastric cancer(75 cases,8.70%),malignant lymphoma(73 cases,8.47%),pancreatic cancer(72 cases,8.35%).Conclusion The malignant tumor mortality rate is higher in males than in females,with the highest mortality observed in those aged 75 and above.Lung,liver and gastric cancers account for most cancer deaths.The hospital managers should strengthen health education for the elderly and simultaneously strengthen the diagnosis and treatment of these key cancers.
6.Correlation analysis of preoperative red blood cell distribution width and prognosis of patients undergoing TACE for hepatocellular carcinoma
Tingsong YING ; Zhixiang FAN ; Hao XU ; Wang LIU ; Rujian WANG ; Qingqiao ZHANG ; Ning WEI ; Yanfeng CUI ; Hongtao LIU
Chinese Journal of Hepatobiliary Surgery 2024;30(3):166-170
Objective:To evaluate the relationship between red blood cell distribution width (RDW) and prognosis of patients with hepatocellular carcinoma (HCC) andergoing transcatheter arterial chemoembolization (TACE).Methods:Clinical data of 212 patients with HCC andergoing TACE for the first time in Department of Interventional Radiology, the Affiliated Hospital of Xuzhou Medical University from January 2011 to May 2018 were retrospectively analyzed, including 184 males and 28 females, aged (56.8±11.2) years. Follow-up for survival. X-tile software was used to determine 13.1% as the optimal threshold for preoperative RDW prediction of prognosis, and enrolled patients were divided into a low level group (RDW<13.1%, n=70) and a high level group (RDW≥13.1%, n=142). Aspartate aminotransferase, total bilirubin, albumin, hemoglobin and lipoprotein a, Barcelona clinical liver cancer (BCLC) stage and other indexes were compared between the two groups. Survival analysis was performed by Kaplan-Meier method, survival rate was compared by log-rank test, and the effect of RDW on prognosis was analyzed by Cox regression. Results:The 1-year, 2-year and 3-year cumulative survival rates in RDW high level group were 34.5%, 14.1% and 6.3%, respectively, while those in RDW low level group were 64.3%, 38.6% and 21.4%, respectively, with significant difference ( χ2=23.09, P<0.001). Compared with the low level group, the levels of aspartate aminotransferase and total bilirubin were higher, the levels of albumin, hemoglobin and lipoprotein a were lower, the proportion of portal vein cancer thrombin was higher, and the stage of BCLC was later, with statistical significance (all P<0.05). Cox regression analysis showed that HCC patients with RDW≥13.1%( HR=1.732, 95% CI: 1.223-2.452, P=0.002) had poor survival prognosis after TACE. Conclusion:Preoperative RDW≥13.1% is an independent risk factor for survival after TACE in patients with HCC. RDW has potential predictive value for prognosis of patients with HCC.
7.Practice and exploration of graduate student management by form teachers in radiation health scientific research institutes
Ziwei WANG ; Hongtao WANG ; Yanqing HAN ; Yaohua FAN ; Jiachen LIU ; Cong XI
Chinese Journal of Radiological Health 2024;33(3):331-335
Graduate education is critical for cultivation of high-level talents and promotion of technological innovation. Strengthening the management of graduate education is of great practical significance for ensuring and improving the quality of graduate education. The expansion of graduate education brings challenges to educational resources and management models, requiring research institutions to ensure educational quality and adapt to social needs. Based on the particularity of research institutes, this article takes the practice of radiation health graduate education as an example to explore the graduate student management elements of form teachers in research institutes. Our research provides a reference for improving the management level of graduate students in research institutes. Graduate form teachers are organizers, implementers, and mentors of graduate ideological education, academic culture, daily management, employment and entrepreneurship, and mental health education. They play an important role as a bridge and link in graduate education and cultivation. Faced with the challenges of graduate education in the new era, form teachers should continuously explore work methods that adapt to the needs of the era. They should also focus on reinforcing ideological and political theories, improving professional skills, establishing and improving management systems, and leveraging the role of student cadres to ensure the high-quality development of graduate education in research institutes.
8.Translation and validation of Chinese version fear of falling avoidance behaviour questionnaire
Ying SHEN ; Hongtao LIANG ; Yan ZHANG ; Fan WANG ; Yan SONG
Modern Clinical Nursing 2024;23(5):19-24
Objective To introduce and translate the fear of falling avoidance behaviour questionnaire(FFABQ)into a Chinese version and test its reliability and validity.Methods The Brislin translation model was employed to translate and back-translate the original FFABQ.The back-translated FFABQ was modified based on expert consultations and a pre-survey,followed by cultural adaptation evaluation.To assess the reliability and validity of the Chinese version FFABQ(FFABQ-CHN),a convenient sampling method was used to select a total of 269 elderly patients from a general hospital in Xi'an to participate the survey.The item analysis,content validity,exploratory factor analysis,Cronbach α coefficient,split-half reliability,test-retest reliability and paired t-test were employed in the evaluation of the reliability and validity of FFABQ-CHN.Results The Chinese version FFABQ comprised 3 dimensions of walking,daily activities and work/leisure activities,with 14 items in total.A total of 254 patients had responded to the survey.Item analysis revealed that CR values of the 14 items ranged from 3.978 to 11.755(all P<0.05),with correlation coefficients between each item and the total score of the questionnaire from 0.473 to 0.930(all P<0.001).The content validity index at the item level ranged from 0.834 to 1.000,while the content validity index at the scale level was 0.968.Exploratory factor analysis extracted three common factors,with a cumulative variance contribution rate of 85.347%.The Cronbach α coefficient,half-half reliability and test-retest reliability of the questionnaire were 0.929,0.877,and 0.954,respectively.Paired t-test indicated no significant difference between the scores(all P>0.05).Conclusions The Chinese version FFABQ demonstrates strong a reliability and validity in the assessment of activity restriction related to fear of falling in the elderly.Thus,it serves as an effective tool for medical practitioners in evaluation of the restrictions in fear-of-falling-related activities of the elderly.
9.Application of distance education in radiological health continuing education and training
Cong XI ; Yaohua FAN ; Hongtao WANG ; Ziwei WANG
Chinese Journal of Radiological Health 2023;32(3):341-343
The implementation of distance education in radiological health continuing education and training was analyzed to provide a reference for improving the quality of radiological health continuing education. The significance, measures, and advantages revealed that the application of distance education in radiological health continuing education and training was conductive to improving the quality of training and fulfilled the needs of radiological health technicians for high-quality training resources. In the future, we will continue to implement and improve distance education, promoting the high-quality development of radiological health continuing education and training.
10.Analysis of national quality control testing training on radiodiagnostic and radiotherapy equipment from 2018 to 2022
Cong XI ; Yaohua FAN ; Hongtao WANG ; Ziwei WANG
Chinese Journal of Radiological Health 2023;32(4):470-473
Objective To analyze the implementation of national training on quality control testing of radiodiagnostic and radiotherapy equipment from 2018 to 2022, and to summarize the effects of the training program. Methods We collected and analyzed the information on the national training program for quality control testing of radiodiagnostic and radiotherapy equipment organized by the National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention from 2018 to 2022. Results Five sessions of national training on quality control testing of radiodiagnostic and radiotherapy equipment were conducted from 2018 to 2022, with each session lasting four days. The proportion of teachers with senior professional titles was 87.5% (35/40). There were a total of 1045 attendances for radiological technician training, among which 75.1% (785/1045) had intermediate or lower technical titles and 87.1% (910/1045) had a bachelor’s degree or above. The qualified rate of training was 97.7% (905/926). In terms of the content, arrangement, and other key parts of training, the degrees of satisfaction of the trainees were all above 96.0%. Conclusion The national training program for quality control testing of radiodiagnostic and radiotherapy equipment worked well, with both the qualified rate and satisfaction degree above 95.0%. The program has helped professionals better understand and master the quality control testing of radiodiagnostic and radiotherapy equipment, and improved the high-quality development of continuing radiological education.

Result Analysis
Print
Save
E-mail